remeditex  portfolio profile mission team portfolio news portfolio apollo endosurgery bio medical miragen therapeutics navitor pharmaceuticals peloton therapeutics quartet medicine menlo therapeutics view larger map news portfolio team mission profile  remeditex ventures llc  north harwood suite  dallas tx 5 map phone   email innovationremeditexcom remeditex  news profile mission team portfolio news news portfolio company quartet medicine announces strategic partnership with merck httpsquartetmedicinecomwpcontentuploadsquartetmedicineannouncesstrategicpartnershipwithmerckpdf apollo endosurgery receives fda approval for an innovative nonsurgical weight loss solution httpapolloendocomapolloendosurgeryincannouncesfdaapprovaloftheorberaintragastricballoonanonsurgicalsolutiontoassistpatientsinweightloss portfolio company tigercat pharma announces positive phase ii results httptigercatpharmacomvelocitypharmaceuticaldevelopmentllcandtigercatpharmaincannouncephaseresultsforvpdinpatientswithchronicpruritusmore apollo endosurgery’s lapband system featured on “the dr oz show” httpapolloendocomthedrozshowfeatureslapbandsystem miragen compound reverses pulmonary fibrosis httpmiragentherapeuticscomnewsreleaseresearchfindingsdemonstratemiragentherapeuticssyntheticmicrorna9mimicpromir9reversespulmonaryfibrosis bio enrolls subjects in early feasibility pilot study httpwwwprnewswirecomnewsreleasesbiomedicalenrollssubjectsinthenewusfdaearlyfeasibilitypilotstudyfortheangelcatheter505html tigercat pharma doses first patient in prurigo nodularis phase ii study httpwwwvpdnetpressreleasesvpdhtml portfolio company apollo endosurgery completes acquisition of obesity intervention division httpapolloendocomapolloendosurgerycompletesacquisitionofallerganincsobesityinterventiondivision remeditex supports promising research with san antonio scientist httpwwwuthscsaeduhscnewssingleformataspnewid portfolio company miragen named one of the most promising biotech companies of  httpwwwmiragentherapeuticscomseptember   remeditex ventures funds innovative medical device company httpwwwbiomedicalcomnewsbiomedicalraisesm remeditex ventures leads series b financing in boulder based microrna company miragen httpwwwmiragentherapeuticscomapril   remeditex is a key investor in an austin based medical device company httpwwwapolloendocomnewseventspressreleasesapolloendosurgeryannouncesmfinancingaspx remeditex supports an early stage dallasbased oncology company httpwwwprnewswirecomnewsreleasespelotontherapeuticscompletesmillionseriesafinancing9html view larger map news portfolio team mission profile  remeditex ventures llc  north harwood suite  dallas tx 5 map phone   email innovationremeditexcom remeditex profile mission team portfolio news bridging the gap through careful analysis calculated risks and investments in ground breaking companies remeditex ventures provides the business and scientific discipline to translate promising scientific discovery into the marketplace to improve our health and wellbeing more info news recent update on news  events bellicum pharmaceuticals enters the public markets more info mission promising technologies our mission is to drive promising scientific discovery into the marketplace more info profile commercial validation remeditex aims to validate translational research into products and therapies for diseases with great need more info team get to know the members mr creecy is chief executive officer and a director of remeditex ventures after serving as president and chief more info portfolio our portfolio learn more about the companies we’ve backed more info   view larger map news portfolio team mission profile  remeditex ventures llc  north harwood suite  dallas tx 5 map phone   email innovationremeditexcom bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version remeditex  team profile mission team portfolio news team john creecy chief executive officer mr creecy is chief executive officer and a director of remeditex ventures after serving as president and chief executive officer of hunt petroleum corporation prior to that mr creecy served as chief operating officer of hodges company inc mr creecy is a graduate of texas tech university with a bachelors degree in accounting and holds a master of science degree in tax from north texas state university now the university of north texas mr creecy is a member of both the dallas assembly and the dallas citizens council civic organizations comprised of business leaders in dallas brett ringle president mr ringle is president and a director of remeditex ventures and most recently was with hunt petroleum as vice president and director prior to that he was a partner at the law firm jones day he graduated from the university of texas at austin with ba and holds a jd from the university of texas law school claire aldridge phd vice president venture development dr aldridge is vice president venture development for remeditex ventures she came to remeditex from utsw where she held numerous positions most recently as director commercialization relations in the office for technology development this office was responsible for the commercialization of scientific discoveries made by the clinical and research faculty dr aldridge received her bs degree in biomedical science from texas am university and her phd in immunology and genetics from duke university john elwood vice president business development mr elwood is vice president business development for remeditex ventures after serving as associate director utsw in the office for technology development there he managed academic projects with commercial potential and helped form companies he was instrumental in forming and operating ut southwesterns biomedical incubator called pipeline at biocenter prior to utsw john held a variety of operational and business development positions at cumbre pharmaceuticals in dallas and sugen and tularik inc in south san francisco he also served as a consultant for companies in north carolinas research triangle and triad areas he has a ba in biology from the university of virginia and a mba from the university of san francisco board of directors peggy oglesby allison peggy allison has been a civic leader in dallas for many years after receiving her bachelor€s degree in philosophy from smith college she continued her studies earning a master€s in mathematics from southern methodist university and completing graduate work in number theory at cambridge university in england in addition to careers in investment management she has also provided her exceptional leadership and enthusiasm to community endeavors including the dallas junior league the science place child care dallas and the museum of science and nature colleen mchugh jd colleen mchugh is a highly regarded texas lawyer with a distinguished record of public and professional service she was the first woman chairman of the university of texas system board of regents and of the texas public safety commission as vice chairman of the board of regents ms mchugh chaired the health affairs committee she served as the board of regents athletics liaison and on the board of directors of the university of texas investment management company utimco the texas department of public safetys diverse divisions include the texas highway patrol and the texas rangers the lawyers of texas elected ms mchugh state bar of texas president for the bars 99 term as president ms mchugh led the successful legislative effort to increase legal services funding for disadvantaged texans she was the first woman to chair the state bar of texas board of directors a strategic advisor and goal oriented lawyer ms mchugh is recognized for her innovative and pragmatic approach to managing complex issues business leaders rely on her good judgment communication skills and problemsolving ability she is employed as vice president compliance risk management and privacy officer for christus spohn health system ms mchugh is board certified in labor and employment law by the texas board of legal specialization and is a member of the highly regarded american law institute the organization responsible for publishing the restatement of law series ms mchugh is a member of the american bank na board of directors ms mchugh received her undergraduate degree from southern methodist university and her law degree from st marys university school of law clay m hunt clay m hunt is cofounder and owner of atropos exploration company an independent oil and gas exploration company focusing most operations in the west texas natural gas fields prior and in addition to establishing atropos exploration clay is also cofounder and owner of texana resources corporation atropos production corporation indefatigable corporation mclean investment hotspur lp and irion county properties clay focuses his energy in drilling and production as well as gas contract services clay served as a director on the boards of dallas bancshares and compass bank north texas he is currently on the board of coastal cookie company and park cities bank he is a past president of the dallas petroleum club clay served on the district leadership council for highland park independent school district and highland park sports club clay earned a bba degree from the university of texas at austin in  view larger map news portfolio team mission profile  remeditex ventures llc  north harwood suite  dallas tx 5 map phone   email innovationremeditexcom john elwood remeditex ventures llc profile  biography  bloomberg feedback john elwood vpbusiness development remeditex ventures llc career history vpbusiness development remeditex ventures llc present assoc director university of texas southwestern medical center former sugen inc former tularik inc former show more website wwwremeditexcom corporate information address  north harwood suite  dallas tx 5 united states phone  fax  web url wwwremeditexcom from the web personal information education university of virginia bachelors degree biology university of san francisco mba sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data executive telephony success stories  remeditex ventures llc newsletter signup enter your email address below to receive our newsletter success stories remeditex ventures llc we were having dropped calls and poor phone quality so we hired executive telephony we were able to keep our polycom phones no longer have dropped calls our call quality is outstanding and we have access to telephone features we did not have before we would highly recommend executive telephony angie stockman office manager remeditex ventures llc view all success stories  home  products  support  consulting  about us  contact copyright š  executive telephony inc all rights reserved designated trademarks and brands are the property of their respective owners microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext0 about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext05 where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext0 personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext0 personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext09 personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows 0 click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft   remeditex ventures llc company profile  bloomberg feedback remeditex ventures llc private company company profile sector financials industry asset management subindustry private equity remeditex ventures llc operates as a venture capital firm the company invests in life sciences therapeutics technologies pharmacy biomedical science diagnostics and biotechnology companies remeditex ventures serves customers in the united states corporate information address  north harwood suite  dallas tx 5 united states phone  fax  web url wwwremeditexcom board members chief executive officer company john creecy remeditex ventures llc president company brett ringle remeditex ventures llc board members company from the web key executives john creecy chief executive officer brett ringle president john elwood vpbusiness development claire aldridge vpventure development sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data the remeditex ventures llc  dallas tx  company information products resources my account talk to a db advisor 0 business directory tx dallas the remeditex ventures llc t the remeditex ventures llc claim this business 5 cedar springs rd  0 dallas tx 5 get directions   business info founded  incorporated tx annual revenue 50 employee count  industries  contacts john w creecy contact business your email address subject message send message company summary the remeditex ventures llc is incorporated in texas has  employees and estimated revenues of 50 verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   t view additional data select from over 5 networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call 0 to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved remeditex ventures backs vpds tigercat pharma  pe hub subscribe to pe hub wire join over 0 of your peers get the mustread email for pevc professionals delivered to your inbox daily — for free us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions subscribe yes no registersign in a community for professionals in private capital remeditex ventures backs vpd’s tigercat pharma august   by iris dorbian print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub remeditex ventures backs vpds tigercat pharma remeditex ventures has made an investment in tigercat pharma a pharmaceutical development company managed by velocity pharmaceutical development no financial terms were disclosed the investment is in conjunction with a collaboration agreement signed by vpd and remeditex continue reading on pe hub writes remeditex ventures has made an investment in tigercat pharma a pharmaceutical development company managed by velocity pharmaceutical development no financial terms were disclosed the investment is in conjunction with a collaboration agreement signed by vpd and remeditex press release south san francisco calif and dallas aug   prnewswire — velocity pharmaceutical development llc “vpd” and remeditex ventures llc “remeditex” announced today the signing of a collaboration agreement under this agreement vpd and remeditex will jointly evaluate pharmaceutical development opportunities for management by the vpd development team and potential funding from velocity pharmaceutical holdings llc and remeditex in conjunction with this collaboration both vpd and remeditex have announced an investment by remeditex in a vpdmanaged pharmaceutical development company tigercat pharma inc “vpd has assembled a worldclass group of scientists and drug developers” said dennis stone chief scientific officer of remeditex “everyone at remeditex is thrilled to be working with the vpd team we look forward to identifying and developing a series of promising pharmaceutical candidates in partnership with vpd” “it is a great honor for us to join in this partnership with remeditex” said david collier ceo of vpd “the remeditex team network and experience perfectly complement the skill set we have at vpd having remeditex as a potential funding partner greatly expands the scope of opportunities we can address at vpd” about velocity pharmaceutical development llc vpd is a pharmaceutical development organization dedicated to rapidly advancing promising drug candidates to clinical proof of concept using a highly virtual management model vpd seeks to acquire promising drug candidates generally within a year of their entering human clinical trials or after initial human clinical data have been generated vpd then manages a highly virtual development program for each drug candidate intended to generate convincing human proof of concept data generally by conducting a phase  clinical trial following successful human proof of concept vpd then seeks a large pharmaceutical company acquirer for each program vpd is staffed by a seasoned team of clinical drug developers with expertise identifying attractive drug candidates target markets and designing and managing outsourced clinical trials this expert team manages multiple single asset companies to remove the costly overhead and misaligned incentives present in traditional biotechnology company structures vpd operates on a rapid decision principle which identifies drug candidates with the greatest promise and repurposes capital from those that don’t work out early in the process vpd believes this new capitalefficient model will yield attractive new drugs to treat patients with significant unmet clinical needs the company is located in south san francisco california more information is available at wwwvpdnet about remeditex ventures llc remeditex is a company that seeks to develop opportunities in need of commercial validation guidance and capital its mission is to develop early stage biomedical science and make texas and colorado a preferred location for biotechnology companies venture capitalists and entrepreneurs by accelerating the pace of commercialization of biomedical research help create and support a thriving biotechnology industry attract biotech venture capital to texas and colorado and achieve significant returns to support the next generation of promising science more information is available at wwwremeditexcom about velocity pharmaceutical holdings llc velocity pharmaceutical holdings llc is an entity funded by cmea capital that makes investments in highly virtual projectfocused pharmaceutical development companies that are managed by velocity pharmaceutical development llc more information is available at wwwvpdnet and wwwcmeacom print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub remeditex ventures backs vpds tigercat pharma remeditex ventures has made an investment in tigercat pharma a pharmaceutical development company managed by velocity pharmaceutical development no financial terms were disclosed the investment is in conjunction with a collaboration agreement signed by vpd and remeditex continue reading on pe hub writes sign up to our newsletter receive updates from our pe hub wire and top stories of the week newsletters first name last name email address us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions you are now subscribed to the pehub wire and top stories of the week newsletters buyouts insiderargosy group llc produces several free newsletters that are sent directly to the email you provide at registration namely pe hub wire pe hub canada wire pe hub wire top story of the week buyouts daily and vcj alert to enable us to keep providing these services free of charge we reserve the right to contact you with special invitations to sample or purchase private equityrelated products by submitting this free subscription request for any of these products you are also consenting to this communication should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email this will discontinue both the special invitations mentioned previously as well as your subscription to the weekly newsletter the information you provide will be safeguarded by argosy group llcbuyouts insider the company’s subsidiaries may use it to keep you informed of relevant products and services we occasionally allow reputable companies outside of the company to mail details of products which may be of interest to you as an international group we may transfer your data on a global basis for the purposes indicated above we will never share your email or contact details with any outside company however should you have any questions please do not hesitate to contact us email protected top posts new oil and gas company native racks up 0 mln by iris dorbian bain capital double impact funds two companies by iris dorbian kkr to buy nature’s bounty from carlyle by luisa beltran blackrock leads funding round for fintech platform icapital by iris dorbian platinum equity to buy united site services by luisa beltran the pe hub podcast episode two by staff report private equity jobs of the week priceline kpmg novaquest are hiring by eamon murphy the carveout curveball by pehublogger network remeditex  profile profile mission team portfolio news profile innovative life science companies are engaging in promising cuttingedge biomedical research to address significant needs in the healthcare marketplace traditional venture capital firms consider many of these efforts too early stage and too risky yet some of these technologies have the potential to benefit patients and transform how certain diseases are managed remeditex was formed to invest in these high quality novel projects that are judged to have reasonable prospects for commercial success our goal is to validate translational research making it attractive to a more expansive group of investors view larger map news portfolio team mission profile  remeditex ventures llc  north harwood suite  dallas tx 5 map phone   email innovationremeditexcom